A wave of excitement swept through medical science in 2003 when the first sequencing of the human genome was completed. News stories were full of enthusiastic predictions of a revolution in health care.
Cardiologists at UAB Hospital are the first in Alabama to treat coronary artery disease patients with a new dissolving heart stent. The Abbott's Absorb bioresorbable vascular scaffold (BVS), FDA approved for use in July, gradually dissolves and may be a safer option for patients in the future.
You may not be getting all you can out of your browsing experience
and may be open to security risks!
Consider upgrading to the latest version of your browser or choose on below: